Global Patent Index - EP 3532086 A1

EP 3532086 A1 20190904 - NOVEL BISPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE FOR TREATING CANCER

Title (en)

NOVEL BISPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE FOR TREATING CANCER

Title (de)

NEUARTIGES BISPEZIFISCHES DOPPELSTRÄNGIGES OLIGONUKLEOTID ZUR BEHANDLUNG VON KREBS

Title (fr)

NOUVEL OLIGONUCLEOTIDE DOUBLE BRIN BISQUECIFIQUES POUR LE TRAITEMENT DES CANCERS

Publication

EP 3532086 A1 20190904 (FR)

Application

EP 17800566 A 20171027

Priority

  • FR 1660441 A 20161027
  • FR 1757591 A 20170808
  • FR 2017052976 W 20171027

Abstract (en)

[origin: WO2018078303A1] The invention relates to a double-stranded oligonucleotide for the use thereof in the prevention and/or treatment of cancer, in association with a therapy that causes damage to DNA or prevents the repair thereof. The invention relates to a double-stranded oligonucleotide for the use thereof in the prevention and/or treatment of cancer, with the exception of androgen-dependent prostate cancer.

IPC 8 full level

A61K 38/14 (2006.01); A61K 31/337 (2006.01); A61K 31/513 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 38/18 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01)

CPC (source: EP US)

A61K 31/337 (2013.01 - EP); A61K 31/7105 (2013.01 - EP); A61K 31/713 (2013.01 - EP); A61K 38/14 (2013.01 - EP); A61K 38/18 (2013.01 - EP); A61K 45/06 (2013.01 - EP US); A61P 35/00 (2017.12 - EP US); C12N 15/113 (2013.01 - US); C12N 15/63 (2013.01 - US); C12N 2310/14 (2013.01 - US); C12N 2310/31 (2013.01 - US); C12N 2310/32 (2013.01 - US)

Citation (search report)

See references of WO 2018078303A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2018078303 A1 20180503; CA 3041630 A1 20180503; CN 110114076 A 20190809; EP 3532086 A1 20190904; JP 2020500217 A 20200109; US 2021292755 A1 20210923

DOCDB simple family (application)

FR 2017052976 W 20171027; CA 3041630 A 20171027; CN 201780079852 A 20171027; EP 17800566 A 20171027; JP 2019546085 A 20171027; US 201716345610 A 20171027